Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On
View:
Post by bassini on Dec 06, 2022 6:32pm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On

Here we go
Comment by Trogarzon on Dec 06, 2022 6:38pm
It really immaterial BS.  This has no merrit... it's a biotech trial and this happens and it's part of it.  These ambulance chaser will do this when Walt Disney has a bad quarter.... it's completly without merrit.
Comment by PWIB123 on Dec 06, 2022 11:10pm
These guys are amubulance chasers.  Who was that guy on here emailing all the law firms?  Sounds like he found one.  These lawsuits never, never ever benefit shareholders.  The law firms always win.  All THTX had to do was hold a conference call to inform investors, but now they are going to have to manage multiple fronts and deal with the dark cloud of an overhanging ...more  
Comment by Marcel49 on Dec 07, 2022 10:07am
Now with the ambulance chasers aroud we can be sure THTX wil stay silent. I agree with PWIB 123. This company have a good basement with her sale where Paul made a good job to increase the sale. For TH1902 let time make the job again. Find a company who have succes the first time with a new drug. I have the same deception like everybody but it doesn't change my mind about the future success of ...more  
Comment by Trogarzon on Dec 07, 2022 10:21am
You do a call and you tell shareholders what's your PLAN in simple strait forward WORDS.  You put Beliveau and Rottenberg on the CALL and you make an argument for your trial EVEN if you don't have the complete plan YET.  You REPEAT that the company can be CASFLOW positive pretty quickly in the MEANTIME.  You put on a STRAIT FACE and you tell the story how it is and you dont ...more  
Comment by Trogarzon on Dec 07, 2022 10:27am
AND you GIVE AWAY nash P3 for WHATEVER you can get to make it REAL in the eye of the market.  Get it STARTED before it'S history.. screw the UPFRONT and get 10% on the OUTCOME....
Comment by houbahop on Dec 07, 2022 4:52am
Who bought 7.5m shares of THTX on November 14th? The way Theratechnologies has been behaving with its shareholders for the last 15 years merits a class action. On the other side, all the members of Thera Fan Club using this forum are very much aware the Board of Directors has been mismanaging its fiduciary duties during all this period. The high turnover of people sitting in the Investor ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities